Cargando…
Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
BACKGROUND: Psoriasis is a debilitating autoimmune skin disease that affects 2%–3% of the world’s population. Patients with moderate-to-severe plaque psoriasis suffer from a decreased quality of life as well as comorbidities. Newer biological agents have been shown to be more effective than traditio...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600940/ https://www.ncbi.nlm.nih.gov/pubmed/23515267 http://dx.doi.org/10.2147/CCID.S42424 |